Nasal ventilation interface and system
A ventilation interface and system is described which can be adapted to be connected to a source of ventilation. The ventilation interface and system may include variable exhaust ports. The ventilation interface system may optionally include feed tubes, y-connector, tube holder, and headgear.
Latest Innomed Technologies, Inc. Patents:
This application is a continuation in part of application Ser. No. 10/910,616, filed on Aug. 4, 2004 and claims benefit under 35 U.S.C. 120. Also, this application claims benefit under 25 U.S.C. 120 to application Ser. No. 10/830,034 filed Apr. 23, 2004, of which application Ser. No. 10/910,616 was a continuation in part. Additionally, this application claims the benefit to U.S. Provisional Patent Application No. 60/501,028, entitled “Ultimate Performance Cannula,” filed Sep. 9, 2003, and U.S. Provisional Patent Application No. 60/492,282, entitled “Variable Exhaust Ports,” filed Aug. 5, 2003, the disclosures of which are expressly incorporated by reference herein in their entirety.
BACKGROUND OF THE INVENTION1. Field of the Invention
Exemplary embodiments of the invention are directed to a nasal ventilation interface adaptable to be connected to a source of ventilation.
2. Discussion of Related Art
Obstructive sleep apnea syndrome (commonly referred to as obstructive sleep apnea, sleep apnea syndrome, and/or sleep apnea) is a medical condition which includes repeated, prolonged episodes of cessation of breathing during sleep. During a period of wakefulness, the muscles of the upper part of the throat passage of an individual keep the passage open, thereby permitting an adequate amount of oxygen to flow into the lungs. During sleep, the throat passage tends to narrow due to the relaxation of the muscles. In those individuals having a relatively normally sized throat passage, the narrowed throat passage remains open enough to continue to permit the adequate amount of oxygen to flow into the lungs. However, in those individuals having a relatively smaller sized throat passage, the narrowed throat passage prohibits the adequate amount of oxygen from flowing into the lungs. Additionally, a nasal obstruction, such as a relatively large tongue, and/or certain shapes of the palate and/or the jaw of the individual further prohibit the adequate amount of oxygen from flowing into the lungs.
The individual having the above-discussed conditions can stop breathing for one or more prolonged periods of time (e.g., 10 seconds or more). The prolonged periods of time during which breathing is stopped, or apneas, are generally followed by sudden reflexive attempts to breathe. The reflexive attempts to breathe are generally accompanied by a change from a relatively deeper stage of sleep to a relatively lighter stage of sleep. As a result, the individual suffering from obstructive sleep apnea syndrome generally experiences fragmented sleep that is not restful. The fragmented sleep results in one or more of excessive and/or inappropriate daytime drowsiness, headache, weight gain or loss, limited attention span, memory loss, poor judgment, personality changes, lethargy, inability to maintain concentration, and/or depression.
Other medical conditions can also prevent individuals, including adults and infants, from receiving the adequate amount of oxygen into the lungs. For example, an infant who is born prematurely can have lungs that are not developed to an extent necessary to receive the adequate amount of oxygen. Further, prior to, during, and/or subsequent to certain medical procedures and/or medical treatments, an individual can be unable to receive the adequate amount of oxygen.
Under these circumstances, it is known to use a ventilation interface to apply a positive pressure to the throat of the individual, thereby permitting the adequate amount of oxygen to flow into the lungs. In the known ventilation interface, oxygen and/or room air containing oxygen is delivered through the mouth and/or nose of the individual. Known types of positive pressure applied by the known ventilation interface include continuous positive airway pressure (CPAP) in which a positive pressure is maintained in the throat passage throughout a respiratory cycle, bi-level positive airway pressure (BiPAP) in which a relatively high positive pressure is maintained during inspiration and a relatively low positive pressure is maintained during expiration, and intermittent mechanical positive pressure ventilation (IPPV) in which a positive pressure is applied when apnea is sensed (i.e., the positive airway pressure is applied intermittently or non-continuously).
One conventional ventilation interface for the application of such positive pressures includes a face mask that covers the nose and/or mouth, as well as a pair of nasal pillows that are inserted into corresponding nares of the naris.
In the conventional art, pressure must be applied between the required harness and the head of the individual to maintain the required seal. As a result, the harness is generally uncomfortable to wear, particularly when sleeping. The applied pressure often results in undesirable irritation and sores caused by movement of the mask and harness during periods of both wakefulness and sleep. Further, the required seal is generally difficult to maintain when the mask and harness is moved. The mask also generally applies an undesirable pressure to the sinus area that is adjacent to the nose, causing the nasal sinus airways to narrow. This causes an increase in the velocity of flow through the upper anatomical airways and a decrease in the lateral pressure against the nasal mucosal walls. Additionally, the tubing may fold undesirably exacerbating the above problem. The above-discussed combination of increased flow velocity and decreased pressure results in the removal of moisture from the mucosal walls during inspiration and may cause an undesirable drying and a burning sensation within the nares. As a result, the individual may remove the mask to alleviate these discomforts, consequently discontinuing the beneficial application of the positive pressure. Additionally the decreased pressure and increased air flow velocity deteriorate the laminar flow between the air input and output portions of the conventional mask.
For these reasons, it is desirable to provide an improved nasal ventilation interface that overcomes one or more of the above-discussed disadvantages.
SUMMARY OF THE EXEMPLARY EMBODIMENTS OF THE INVENTIONA first exemplary embodiment of the present invention provides a nasal ventilation interface including a cannula connectable to a source of ventilation gas via at least two ventilation connectors including at least one reservoir flange in close proximity with at least one nasal insert. The nasal ventilation interface further includes a seal portion positioned on a distal end of the at least one nasal insert and a central reservoir with at least one exhaust flange and an exhaust port positioned at a midpoint between the at least two ventilation connectors.
In a second exemplary embodiment, a nasal ventilation interface includes a cannula connectable to a source of ventilation gas via at least two ventilation connectors forming a first inflow portion. A reservoir flange forms a second inflow portion with at least one nasal insert. The nasal insert forms a third inflow portion and a first outflow portion. A seal portion with a substantially oval cross section is positioned on a distal end of the nasal insert. A central reservoir forms a second outflow portion. At least one exhaust flange forms a third outflow portion. An exhaust port positioned at a midpoint between the at least two ventilation connectors forms a fourth outflow portion and a fifth outflow portion.
A third exemplary embodiment describes a ventilation interface system. The system may include feed tubes, a y-connector and headgear engageable with a headgear flange on a cannula. The ventilation connectors are connectable to a source of ventilation gas via the feed tubes and y-connector. The at least two ventilation connectors form a first inflow portion. A reservoir flange forms a second inflow portion. At least one nasal insert and seal portion form a third inflow portion and a first outflow portion. A central reservoir forms a second outflow portion. At least one exhaust flange forms a third outflow portion. An exhaust port positioned at a midpoint between the at least two ventilation connectors forms a fourth outflow portion and a fifth outflow portion.
Reference will now be made to the exemplary embodiments of the invention, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts
Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
DETAILED DESCRIPTION OF THE EXEMPLARY EMBODIMENTSThe present invention provides a nasal ventilation interface system that may include a cannula that is configured to be connected to a ventilation source. The cannula may connect to a source of ventilation gas, such as oxygen and/or air containing oxygen. For example, the cannula may include a distal end that connects to a feed tube. The feed tube may then lead to a branch of a y-connector. The y-connector may then have an exterior surface and an interior surface that define a wall portion therebetween, and each of the exterior and interior surfaces may have a substantially circular or oval cross section. The y-connector may then have another branch that is connected with the source of the ventilation gas, such as a mechanical ventilator or some other source of gas. The source may apply a positive pressure through the cannula to the throat of the user, thereby permitting an adequate amount of oxygen or air to flow into the lungs. Although the figures show certain exemplary embodiments of the nasal ventilation system, it is to be understood that the ventilation system can be of any type. One or more exemplary embodiments of the present invention will now be described with reference to the drawings, wherein like reference numbers throughout the several views identify like and/or similar elements.
For example, as shown in
Ventilation connectors 2 couple the cannula 20 to a ventilation source (not shown). Ventilation connectors 2 may be shaped and configured to connect to a wide variety of ventilation sources, such as a mechanical ventilator, pump, or tank. For example, ventilation connectors 2 may be configured to connect to a source of ventilation gas via one or more feed tubes and a y-connector (not shown). Other types of ventilation connectors may be used as part of the cannula 20.
Reservoir flange 4 provides a reservoir for air to flow from the ventilation connector 2 to other parts of the cannula 20. For example, reservoir flange 4 may be coupled to the nasal insert 6, the central reservoir 10, and the exhaust flange 12.
Nasal insert 6 provides a structure for extending the cannula 20 into a user's nares. Nasal insert 6 may comprise at its distal end a seal portion 8. The seal portion 8 may have a substantially oval cross section in order to assist with fitting nasal insert 6 inside a user's nasal passages. The seal portion 8 may also be configured to receive a skirt (not shown) to prevent leakage. Nasal insert 6 may also be coupled at its proximal end to the central reservoir 10.
The seal portion 8 and/or at least one nasal insert 6 may be made of an elastic material. The elastic material may be chosen such that its resiliency is sufficient to retain the cannula 20 in the nares of a user. Further, the seal portion 8 and/or the nasal insert 6 may expand in response to the positive pressure of the ventilation gas, thereby aiding in the retention of the cannula 8 within the nares. The seal portion 8 may be retained entirely in the user's nares by friction between the seal portion 8 and the user's nares. Alternatively, the nasal insert 6 and seal portion 8 may be made of less elastic material that deforms only slightly and instead the cannula 20 may be held in place by headgear (not shown) that is attached to the user.
Central reservoir 10 provides an additional volume of air or gas that, for example, allows for a decreased flow velocity through cannula 20 without a drop in pressure. In addition, central reservoir 10 may be shaped in a variety of ways to optimize the airflow through the cannula 20.
For example, the central reservoir 10 may be shaped to allow a laminar flow through the cannula 20 between the nasal insert 6 and the exhaust port 14. In particular, the central reservoir 10 may have a shape and volume that is sufficient to slow the velocity of air or gas without dropping its pressure. This feature may be considered useful in increasing the effectiveness of the cannula 20 for treating sleep apnea.
During sleep, the exhalation of a person is driven by the elasticity of the lungs. For patients that use conventional sleep apnea devices, the contraction of the lungs during exhalation can become static during sleep, which interrupts the adequate exhalation and release of carbon dioxide. This may happen frequently with patients prescribed with conventional sleep apnea devices that use pressures outside the normal range of 8 cm H2O to 12 cm H2O which may be from 3 cm H2O to 25 cm H2O or higher. These conventional devices sometimes have extreme variations in continuous positive airway pressures, greater than the elasticity of the lung.
In contrast, in accordance with some embodiments of the present invention, a ventilation interface system that uses the cannula 20 with the central reservoir 10 can provide the ventilation gas from the ventilation source to the nares at a lower velocity thereby decreasing a drop in pressure and with improved laminar flow because the central reservoir 10 can hold an increased volume of air or gas. The resulting decrease in flow velocity decreases lateral pressure and in turn decreases the amount of moisture removed from the mucosal walls of a user, which increases the comfort of the user. Accordingly, the ventilation interface system consistent with the principles of the present invention may provide better comfort and functionality and may be more economical to produce over the conventional systems.
Referring now back to
Alternatively, the exhaust port 14 may be configured with a mechanism, such as a dial or valve, which increases or decreases the size of the internal diameter of the exhaust port 14 and varies the exhaust flow. This would enable various settings to be fitted to the various embodiments of the present invention.
As one non-limiting example, a doctor could prescribe a particular aperture setting to accommodate a particular patient's needs, thereby reducing the tendency for incoming pressure to overpower the elasticity of the lungs and prevent exhalation. For example, the mechanism may be helpful for CPAP users or other patients prescribed with excessive pressures ranging from 3 cm H2O to 25 cm H2O or higher. For some patients, the ranges may be from 5 cm H2O to 20 cm H2O, 8 cm H2O to 15 cm H2O or 10 cm H2O to 12 cm H2O.
In addition to treating sleep apnea, the mechanism may be integrated or removable from the cannula 20 and configured to facilitate flow of any type of gas that may be used in a dental office or hospital. For example, the cannula 20 may be fitted with a mechanism to allow for the administration of general anesthesia or other type of gas, such as a local anesthetic gas.
Referring to
Likewise, referring to
Similarly, referring to
Referring again back to
In addition, connection portion 18 may provide a structure for attaching other components to the cannula 20, such as a flange, connector, or loop for a strap or headgear.
Referring now to
The exhaust flange 12 and exhaust port 14 may be configured to smooth the transition of air releasing out of the central reservoir 10. For example, as shown in
Referring now to
During exhalation by the user, the nasal insert 6 forms a first outflow portion 30. The central reservoir 10 then forms a second outflow portion 32. As noted above, the central reservoir 10 may be shaped and configured such that the velocity of outflow portion 32 may be reduced without substantially affecting the pressure of the inflow portions or outflow portions. The exhaust flange 12 then forms a third outflow portion 34. The exhaust port 14 is configured and shaped to form a fourth outflow portion 36 and a fifth outflow portion 38. The fifth outflow portion 38 is then expelled out of exhaust port 14.
The exhaust port 14, the nasal insert 6, and the central reservoir 10 may be configured to allow for improved laminar flow by flow portions 24, 26, 28, 30, 32, and 34. In particular, the volume of the central reservoir 10 creates room for the gas and decreases the flow velocity of these flow portions and decreases the pressure drop. This decrease in flow velocity reduces any dryness and irritation that a user may otherwise have as a result of higher flow velocities which increase the venturi effect along the nasal mucosa membrane. The cannula 20 will increase the desired amount of pressure that prevents the apneas by increasing the number of air molecules. Additionally, the central reservoir 10 may allow for more laminar flow between the inflow portions 24, 26, and 28 and the outflow portions 30, 32, 34, and 36. The central reservoir 10 further reduce the likelihood of any tornadic activity between the second inflow portion 26 and second 32 and third 34 outflow portions.
Furthermore, the exhaust flange 12 and the exhaust port 14 may be shaped and configured to optimize a venturi or similar effect between the third 36 and fourth outflow 38 portions. In particular, the exhaust flange 12 at its top surface 40 may have a certain diameter that decreases as it extends to the exhaust port 14. This narrowing of the exhaust flange 12 and exhaust port 14 may cause a venture effect as outflow portion 36 is expelled into outflow portion 38. As described above, the exhaust port 14 may also include a mechanism, such as an adjustable dial or valve, that adjusts the aperture of the exhaust port 14.
Referring to
Referring now to
Referring to
Referring now to
Numerous additional modifications and variations of the exemplary embodiment of the present invention are possible in light of the above teachings. It is therefore to be understood that within the scope of the appended claims, exemplary embodiments of the present invention may be practiced otherwise than as specifically described herein.
Claims
1. An adjustable slide interface comprising:
- a substantially rectangular slide configured to be attachable to a nasal cannula with at least one flow velocity opening including a flow velocity cut out;
- wherein when the substantially rectangular slide is moved laterally at least one flow velocity opening passes over the flow velocity cut out.
2. The adjustable slide according to claim 1 wherein the substantially rectangular slide mechanism is configured to snap into an exhaust port.
3. The adjustable slide interface according to claim 1 wherein the substantially rectangular slide mechanism is configured be held in an exhaust port by brackets.
4. The adjustable slide interface according to claim 1 wherein the substantially rectangular slide is made from at least one of rubber, plastic, silicone, polyethylene or polyurethane.
1125542 | January 1915 | Humphries |
3097642 | July 1963 | Russell |
3670726 | June 1972 | Mahon et al. |
3674910 | July 1972 | McKenzie |
3739774 | June 1973 | Gregory |
3861385 | January 1975 | Carden |
3902486 | September 1975 | Guichard |
3905381 | September 1975 | Hewson et al. |
3913607 | October 1975 | Price |
4138105 | February 6, 1979 | Hunger et al. |
4156426 | May 29, 1979 | Gold |
4221381 | September 9, 1980 | Ericson |
4267845 | May 19, 1981 | Robertson, Jr. et al. |
4273124 | June 16, 1981 | Zimmerman |
4312359 | January 26, 1982 | Olson |
4367735 | January 11, 1983 | Dali |
4367816 | January 11, 1983 | Wilkes |
4406283 | September 27, 1983 | Bir |
4422456 | December 27, 1983 | Tiep |
4493614 | January 15, 1985 | Chu et al. |
4549542 | October 29, 1985 | Chien |
4587967 | May 13, 1986 | Chu et al. |
4601465 | July 22, 1986 | Roy |
4617637 | October 14, 1986 | Chu et al. |
4660555 | April 28, 1987 | Payton |
4699139 | October 13, 1987 | Marshall et al. |
4706664 | November 17, 1987 | Snook et al. |
4753233 | June 28, 1988 | Grimes |
4774946 | October 4, 1988 | Ackerman et al. |
4899740 | February 13, 1990 | Napolitano |
4915105 | April 10, 1990 | Lee |
4996983 | March 5, 1991 | AmRhein |
5000173 | March 19, 1991 | Zalkin et al. |
5022900 | June 11, 1991 | Bar-Yona et al. |
5025805 | June 25, 1991 | Nutter |
5038772 | August 13, 1991 | Kolbe et al. |
5046491 | September 10, 1991 | Derrick |
5074297 | December 24, 1991 | Venegas |
5113857 | May 19, 1992 | Dickerman et al. |
5121745 | June 16, 1992 | Israel |
5127397 | July 7, 1992 | Kohnke |
5137017 | August 11, 1992 | Salter |
D333015 | February 2, 1993 | Farmer et al. |
5188101 | February 23, 1993 | Tumolo |
5265592 | November 30, 1993 | Beaussant |
5265595 | November 30, 1993 | Rudolph |
5269296 | December 14, 1993 | Landis |
5271391 | December 21, 1993 | Graves |
5280780 | January 25, 1994 | Abel |
5299599 | April 5, 1994 | Farmer et al. |
5335656 | August 9, 1994 | Bowe et al. |
5355893 | October 18, 1994 | Mick et al. |
5372130 | December 13, 1994 | Stern et al. |
5375593 | December 27, 1994 | Press |
5385141 | January 31, 1995 | Granatiero |
5394568 | March 7, 1995 | Brostrom et al. |
5396885 | March 14, 1995 | Nelson |
5398676 | March 21, 1995 | Press et al. |
5400776 | March 28, 1995 | Bartholomew |
5425359 | June 20, 1995 | Liou |
5437267 | August 1, 1995 | Weinstein et al. |
5509409 | April 23, 1996 | Weatherholt |
5526806 | June 18, 1996 | Sansoni |
5533506 | July 9, 1996 | Wood |
5557049 | September 17, 1996 | Ratner |
5682881 | November 4, 1997 | Winthrop et al. |
5740799 | April 21, 1998 | Nielsen |
5794619 | August 18, 1998 | Edelman et al. |
5906203 | May 25, 1999 | Klockseth et al. |
5954049 | September 21, 1999 | Foley et al. |
6561188 | May 13, 2003 | Ellis |
6561193 | May 13, 2003 | Noble |
6571798 | June 3, 2003 | Thornton |
6595215 | July 22, 2003 | Wood |
6637434 | October 28, 2003 | Noble |
6647983 | November 18, 2003 | Smith et al. |
6655385 | December 2, 2003 | Curti et al. |
6679265 | January 20, 2004 | Strickland et al. |
6766800 | July 27, 2004 | Chu et al. |
6848443 | February 1, 2005 | Schmidt et al. |
20020046755 | April 25, 2002 | DeVoss |
20020124849 | September 12, 2002 | Billette de Villemeur |
20050028822 | February 10, 2005 | Sleeper et al. |
20050033247 | February 10, 2005 | Thompson |
20050051176 | March 10, 2005 | Riggins |
20050061326 | March 24, 2005 | Payne, Jr. |
146688 | February 1981 | DE |
0 658 356 | June 1995 | EP |
0532214 | January 1941 | GB |
WO 01/97892 | June 2000 | WO |
WO 2005/079726 | September 2005 | WO |
- SNAPP Nasal Interface, Tiara Medical Systems, Inc. http://www.tiaramed.com/asp—shop/shopdisplayproducts.asp?id=109&cat=SNAPP%2A+NASAL+Interface, viewed May 17, 2005.
Type: Grant
Filed: Dec 9, 2004
Date of Patent: Mar 20, 2007
Patent Publication Number: 20050133039
Assignee: Innomed Technologies, Inc. (Coconut Creek, FL)
Inventor: Thomas J. Wood (Blackshear, GA)
Primary Examiner: Teena Mitchell
Attorney: Maier & Maier, PLLC
Application Number: 11/007,218
International Classification: A61M 16/00 (20060101); A61M 15/08 (20060101);